Memantine Hydrochloride Tablet
Product Images NDC 70518-3338

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 70518-3338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 01)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 02)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 03)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 04)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 05)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 06)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 07)

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 07)
This is a graph displaying the cumulative percentage of patients who took either Placobol/Donopozil or M. HClDonepezil, with ADCS-ADL change from Baseline on the x-axis and percentage of patients on the y-axis. The graph shows that both drugs had a positive effect on patients with Alzheimer's Disease, with M. HClDonepezil having a slightly higher effectiveness. There are no significant data points available to interpret further.*
FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 08)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 09)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Memantine HCI is a medication available in the form of tablets with a strength of 5mg, manufactured by Viena Pharmaceuticals Inc. The drug is available in a pack of 30 tablets and is repackaged by RemedyRepack Inc. The expiry date and lot number of the tablets are not available. The National Drug Code (NDC) for Memantine HCI is 70518-3338-00 and the source NDC is 72578-0003-05. The package insert should be referred to for directions for use. It should be stored at a temperature of 25° (63-77°F), with permitted excursions up to 30°C (59-86°F), as per USP guidelines. The medication should be kept out of the reach of children and is available only through prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.